Prostate cancer decisions — 2022

The Veteran's hypertension and prostate cancer are granted as service-connected due to exposure to herbicide agents during active duty.,Service connection for abnormal glucose/type II diabetes, colon polyps, heart condition, lower extremity radiculopathy/neuropathy, and erectile dysfunction is remanded.

The Veteran's entitlement to continued special monthly compensation (SMC) at the housebound rate was denied as he no longer met the criteria for SMC due to a reduction in his prostate cancer evaluation from 100% to 60%. The Veteran had only one service-connected disability rated at 100%, which is not sufficient to meet the requirements for SMC.

The Veteran's appeal is remanded due to insufficient evidence regarding his need for aid and attendance. The VA needs to obtain recent medical records and schedule a new examination to assess the impact of his service-connected conditions on his daily activities.

The Board has decided that the Veteran's claim for service connection for prostate cancer should be remanded, meaning a new decision is needed.

The Board has determined that the Veteran's death was caused by asbestos exposure during service, and grants service connection for the cause of his death.

The Veteran's service-connected disabilities, including prostate cancer and ischemic heart disease, do not render him unable to secure or follow a substantially gainful occupation.

The Board denied service connection for osteoarthritis of the bilateral ankles and prostate cancer, finding no evidence linking these conditions to military service.

The Board has granted service connection for prostate cancer with metastasis to the bladder and skeletal system, anemia secondary to prostate cancer, and SMC based on the need for aid and attendance. The decision is based on evidence that supports these claims.

The Board has granted service connection for prostate cancer, finding that the Veteran's in-service asbestos exposure is related to his current condition.

The Veteran's claims for IHD/CAD, hypertension, and prostate cancer have been granted. The claims for an acquired psychiatric disorder (PTSD and persistent depressive disorder) and a respiratory disability (shortness of breath) are being remanded.

The Board has remanded the claims for service connection due to potential herbicide exposure in Korea. The Veteran's unit is alleged to have been near the DMZ, but further verification is needed.

The Board has remanded the cases of service connection for a heart disorder, type II diabetes mellitus, and prostate cancer due to unclear exposure information. The AOJ is instructed to obtain additional medical opinions from the clinician who provided the June 2022 VA examination.

The Veteran's claims for diabetes mellitus type II, bilateral lower and upper extremities diabetic neuropathy, and residuals of prostate cancer are granted as they are related to his in-service exposure to Agent Orange. The claim for ischemic heart condition (diagnosed as atrial fibrillation) is remanded due to insufficient rationale provided by the VA examiner.

Service connection for prostate cancer, voiding dysfunction, penile implant, and an acquired psychiatric disorder is denied.,The Veteran's claims of service connection for voiding dysfunction and a penile implant as secondary to his prostate cancer are not supported by the evidence.

The Board has granted service connection for the Veteran's prostate cancer, finding it is related to his in-service exposure at Camp LeJeune. The decision is based on a balance of evidence favoring the Veteran.

The Veteran's claim for service connection for prostate cancer was denied as there is no evidence of direct service connection and the presumption of exposure to herbicide agents does not apply due to lack of documentation.

The Board denied the Veteran's claims for service connection for diabetes mellitus, type II, prostate cancer, urinary bladder cancer, and erectile dysfunction (ED) as secondary to exposure to Agent Orange. The evidence did not establish that the Veteran was exposed to Agent Orange in Vietnam or its offshore waters.

The Board has remanded the claim for a supplemental VA medical opinion to determine if the Veteran's service-connected ischemic heart disease and/or ADT treatment for prostate cancer caused or contributed to his death by cardiac respiratory arrest and metastatic brain cancer.

The Board has determined that the Veteran's cause of death, prostate cancer, may be related to his service exposure to radiation at McClellan Air Force Base. However, due to incomplete STRs and lack of evidence regarding Vietnam service, further investigation is needed.

The Veteran's prostate cancer is granted service connection on a presumptive basis due to herbicide agent exposure during his active duty in Guam and American Samoa, as provided by the PACT Act. The Board found that there was no direct evidence of herbicide agent exposure but conceded exposure based on the PACT Act.